COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions23/04/2018
-   
  Nexstim Plc appoints Sisu Partners as new Certified Adviser23/04/2018
-   
  Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 201823/04/2018
-   
  Novo Nordisk A/S: Share repurchase programme23/04/2018
-   
  Immuron’s Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets23/04/2018
-   
  UPDATE -- Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting23/04/2018
-   
  Sienna Senior Living Announces Redemption of Extendible Convertible Unsecured Subordinated Debentures23/04/2018
-   
  OrthoPediatrics Corp. to Report First Quarter 2018 Financial Results on May 14, 201823/04/2018
-   
  AXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple Indications23/04/2018
-   
  Ceapro Inc. Provides Corporate Update23/04/2018
-   
  Progyny Launches Two How-To Guides to Support Employers and their Employees as they Navigate Infertility in the Workplace23/04/2018
-   
  Vous avez le feu vert pour sauver des vies : Semaine nationale de sensibilisation au don d’organes et de tissus (22-28 avril)23/04/2018
-   
  You have the green light to save a life: April 22-28 is National Organ and Tissue Donation Awareness Week23/04/2018
-   
  Abba Medix Receives its License to Produce Cannabis Oil23/04/2018
-   
  Wildflower Completes Acquisition of Retail and Cultivation Licenses in LA23/04/2018
-   
  AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)23/04/2018
-   
  Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Developments on May 3, 201823/04/2018
-   
  Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug Application for DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia23/04/2018
-   
  Vystar Acquires Assets of NHS Holdings23/04/2018
Pages